It’s been a positive start to the month for the Active Care Group. Two companies within the portfolio have been nominated for several categories at the Case Management Society UK (CSMUK) awards, which take place in London on Friday 13th September.

CMSUK is part of a global organisation of registered Case Managers who are committed to delivering quality case management and adhering to best practice for individuals with spinal cord and acquired brain injuries. Neural Pathways has been nominated for Therapeutic Service Provider of the Year and Anglia Case Management has been nominated for, Therapeutic Service Provider of the Year and Case Management Company of the Year. Anglia’s Joanne Forrest has also been nominated for Case Manager of the Year.

The Royal College of Nursing have also published an online video highlighting examples of good practice at Lane Fox Remeo Respiratory Centre (Remeo) which provides specialist care for individuals with complex respiratory requirements. A link to the video can be accessed via the Remeo website at:

Montreux Capital Management CEO, Oliver Harris, said: “Recognition from The RCN and CMSUK is a great compliment for the Active Care Group, reflecting the hard work of the entire team. Delivering excellent care is at the core of the business, it is always good to see this recognised.”

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.